- Home
- DAWN vs WT Comparison
DAWN vs WT Comparison
Compare DAWN & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | WT |
|---|---|---|
| Founded | 2018 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DAWN | WT |
|---|---|---|
| Price | $21.46 | $16.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $24.43 | $17.33 |
| AVG Volume (30 Days) | 1.8M | ★ 3.0M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ 127.27 |
| EPS | N/A | ★ 0.75 |
| Revenue | $158,182,000.00 | ★ $493,753,000.00 |
| Revenue This Year | $55.03 | $36.19 |
| Revenue Next Year | $28.12 | $8.21 |
| P/E Ratio | ★ N/A | $22.77 |
| Revenue Growth | ★ 20.60 | 15.43 |
| 52 Week Low | $5.64 | $8.02 |
| 52 Week High | $21.50 | $17.87 |
Technical Indicators
Market Signals| Indicator | DAWN | WT |
|---|---|---|
| Relative Strength Index (RSI) | 79.88 | 59.29 |
| Support Level | $10.30 | $15.38 |
| Resistance Level | $21.50 | $17.39 |
| Average True Range (ATR) | 0.03 | 0.67 |
| MACD | -0.33 | 0.31 |
| Stochastic Oscillator | 63.64 | 67.11 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.